Dutch food and nutrition group Royal Numico has announced that an agreement in principle has been reached to sell its subsidiaries Biodermal and Galenco, including the related production facility in Belgium, to Omega Pharma (Belgium).
Go deeper with GlobalData
The combined sales of the two subsidiaries, which are specialised in skincare products, amounted to approximately €15m (US$15.8m) in 2002.
It is expected that the sale will be finalised by the end of March 2003.
Numico has said that these divestments are in line with the strategic review of the company as announced in November 2002, whereby the company will focus on its core activities baby food and clinical nutrition.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
